OptiCept Technologies Year-End Report Q4 2025
OptiCept Technologies AB (publ), today published its Year-End Report for Q4 2025 (January – December 2025).
SIGNIFICANT EVENTS Q4 2025
- Operating profit for the fourth quarter is negatively impacted by non-cash, non-recurring items amounting to 21,7 MSEK.
- OptiCept refinances loans of approximately SEK 21.4 million and receives additional liquidity through a new loan of approximately SEK 17.5 million, as well as establishing a credit facility of SEK 10 million
- An extraordinary general meeting partially elected a new board and followed the nomination committee’s proposal
- OptiCept Technologies AB announces Nomination Committee ahead of the 2026 Annual General Meeting
SIGNIFICANT EVENTS AFTER PERIOD END
- OptiCept expands its global agreement with FPS, secures license revenues of approximately SEK 150 million in the first 5 years, and achieves positive EBITDA in the second half of 2026
- OptiCept Technologies AB launches cost-efficiency program
- Lenders and issuers of credit facilities request early conversion of loans, including arrangement fees and accrued interest, of at least approximately SEK 39.8 million into shares
- Henrik Nettersand assumes the role of Acting CEO following Thomas Lundqvist’s departure from OptiCept Technologies AB
- OptiCept receives two breakthrough orders in French fries through FPS Food Process Solutions
- OptiCept reports positive cutting results from Indonesia
| FINANCIAL OVERVIEW | ||||
| KSEK (unless otherwise stated)* | Q4 (oct-dec) | Q1-Q4 (jan-dec) | ||
| 2025 | 2024 | 2025 | 2024 | |
| Net Sales** | 929 | 5 385 | 27 236 | 17 674 |
| Total revenue** | 1 459 | 8 003 | 37 338 | 32 791 |
| Operating Income | -48 185 | -17 503 | -84 330 | -56 094 |
| Result for the period | -51 306 | -17 531 | -90 488 | -55 699 |
| Inbound Orders*** | 111 | 898 | 27 302 | 12 194 |
| Open orders*** | 7 792 | 7 994 | 7 792 | 7 994 |
| Reported EBITDA | -43 717 | -14 848 | -72 105 | -42 538 |
| Net result for the period | 368 701 | 392 326 | 368 701 | 392 326 |
| Cash & cash equivalents | 2 612 | 21 677 | 2 612 | 21 677 |
| Equity | 278 793 | 362 241 | 278 793 | 362 241 |
| Equity ratio (%) | 76% | 92% | 76% | 92% |
| Average number of shares in the period | 63 138 284 | 55 254 166 | 62 912 827 | 48 300 540 |
| Number of shares at the end of the period | 64 844 683 | 62 769 683 | 64 844 683 | 62 769 683 |
| Earnings per share before and after dilution (SEK) | -0,81 | -0,32 | -1,44 | -1,15 |
| Cash flow from operating activities | -13 866 | -15 461 | -43 574 | -48 263 |
| Total Cash flow | -1 012 | 17 119 | -19 065 | 7 563 |
| For information regarding alternative performance measures, please refer to Note 5. | ||||
| * Rounding may occur so that in some cases the amounts do not add up | ||||
| ** For information regarding net revenue, please refer to Note 2. | ||||
| ***Open orders excluding FPS, please refer to Note 1 | ||||
The report is available on the company's website: https://investor.opticept.se/finansiell-information/finansiella-rapporter/